VIVA BIOTECH HOLDINGS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.62 HKD | -1.59% |
|
-3.12% | -40.95% |
| Mar. 28 | Viva Biotech Holdings Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 18 | Viva Biotech Holdings Appoints WANG Stephen Hui as Non-Executive Director | CI |
Chart calendar Viva Biotech Holdings
e42d6f.JXvvxai3dJKgO5L_O9Oe6VPrSBiOKpQaH34wM87lm2c.azOajcTAQ9PhDaW3ApSuoGOPCVD2f-YjUjwJYIKr0i5rEda10tAk44151w~07f41d21346b88d15b4b78d7219dd085
Upcoming events on Viva Biotech Holdings
Past events on Viva Biotech Holdings
| 2024-03-28 08:06 am | Q4 2023 Earnings Release |
| 2023-08-29 08:48 am | Q2 2023 Earnings Release |
| 2023-08-24 10:00 pm | Extraordinary Shareholders Meeting |
| 2023-06-29 10:00 pm | Annual General Meeting |
| 2023-03-29 | Q4 2022 Earnings Release |
| 2022-08-29 | Interim 2022 Earnings Call |
| 2022-08-29 08:56 am | Interim 2022 Earnings Release |
| 2022-03-28 12:49 pm | FY 2021 Earnings Release |
| 2021-08-29 | Interim 2021 Earnings Release |
| 2021-03-30 07:00 pm | FY 2020 Earnings Release |
| 2020-08-31 11:20 am | Interim 2020 Earnings Release |
| 2020-03-30 11:33 pm | FY 2019 Earnings Release |
| 2019-08-28 11:12 pm | Interim 2019 Earnings Release |
| 2019-08-27 | Interim 2019 Earnings Call |
Past dividends on Viva Biotech Holdings
| 2021-06-15 | Final Payment 0.01 HKD |
| 2020-09-10 | Interim Payment 0.017 HKD |
| 2020-06-14 | Final Payment 0.015 HKD |
| 2019-09-08 | Interim Payment 0.005 HKD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 323 322 0.34% | 697 612 13.89% | 2 104 2 308 -8.83% | 0,00 |
|
EBITDA Million CNY | Released Forecast Spread | 90,2 105 -14.09% | 0,00 0,00 - | 397 496 -20% | 0,00 |
|
EBIT Million CNY | Released Forecast Spread | 56,1 58,5 -4.05% | 116 -76,0 252.06% | 238 411 -41.95% | 0,00 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 281 135 108.09% | -356 -204 -75.04% | 348 591 -41.17% | 0,00 |
|
Net income Million CNY | Released Forecast Spread | 266 112 137.41% | -379 -211 -79.57% | 288 530 -45.71% | -528 |
|
EPS CNY | Released Forecast Spread | 0,18 0,12 57.84% | -0,24 -0,11 -117.14% | 0,08 0,28 -71.07% | -0,28 |
| Announcement Date | 30/03/20 | 30/03/21 | 28/03/22 | 30/03/23 |
Quarterly results
| Fiscal Period | December | 2023 S1 |
|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 1 142 |
|
EPS CNY | Released Forecast Spread | 0,00 0,67 -99.85% |
| Announcement Date | 29/08/23 |
More events
Past sector events for Viva Biotech Holdings
| 2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 05:26 am | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:44 am | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:10 am | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-28 | PFIZER LIMITED: Q4 2024 Earnings Release |
| 2024-05-27 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
| 2024-05-27 08:10 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1873 Stock
- Calendar Viva Biotech Holdings
